Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Mrv (General Partner Meif Ii Equity Em) Limited investment portfolio
Mrv (General Partner Meif Ii Equity Em) Limited has made numerous investments in companies such as Serve First Cx, Neurotherapeutics, and Warehow within the Health Tech sector.
vc
Portfolio
3
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (3)
| Company | Sector | Source | Last confirmed on |
|---|---|---|---|
| Neurotherapeutics Ltd NEUROTHERAPEUTICS LTD, operating under the name Neupulse, is a neurotechnology company that develops non-invasive neuromodulation solutions. The company's primary product is a wearable wrist-worn device designed to reduce tics for individuals with Tourette Syndrome and other tic disorders. | Health TechDeepTech | Confirmed | 2026-02-10 |
| Serve First Cx Ltd SERVE FIRST CX LTD provides an AI-driven customer experience and feedback management platform that aggregates data from sources such as surveys, online reviews, and mystery shopping to deliver actionable insights and automated workflows to frontline teams. The company targets enterprise clients across the retail, hospitality, wellness, and facilities management sectors to help them optimize customer loyalty and operational performance. | Software & IT | Confirmed | 2026-01-13 |
Shareholding changes (3)
Mrv (General Partner Meif Ii Equity Em) Limited's positions across portfolio companies2026
- SEED 1 ORDINARY SHARES 12,664 → 36,349
- ORDINARY A 0 → 360,972
Articles (1)
- Neupulse Secures Latest Seed Funding Round of £213.3k1 May 2026Neurotherapeutics